MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 234 filers reported holding MYRIAD GENETICS INC in Q1 2016. The put-call ratio across all filers is 2.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $18,936,000 | +27.4% | 586,420 | +20.7% | 0.00% | +33.3% |
Q2 2021 | $14,861,000 | -11.3% | 485,986 | -11.7% | 0.00% | -25.0% |
Q1 2021 | $16,753,000 | +15.8% | 550,193 | -24.8% | 0.00% | +33.3% |
Q4 2020 | $14,461,000 | +68.7% | 731,258 | +11.2% | 0.00% | +50.0% |
Q3 2020 | $8,572,000 | +4.3% | 657,358 | -9.3% | 0.00% | 0.0% |
Q2 2020 | $8,217,000 | -34.7% | 724,583 | -17.6% | 0.00% | -50.0% |
Q1 2020 | $12,585,000 | -48.3% | 879,477 | -1.7% | 0.00% | -42.9% |
Q4 2019 | $24,362,000 | -4.9% | 894,689 | 0.0% | 0.01% | -12.5% |
Q3 2019 | $25,615,000 | -11.1% | 894,689 | -13.7% | 0.01% | -11.1% |
Q2 2019 | $28,804,000 | -25.4% | 1,036,869 | -10.8% | 0.01% | -25.0% |
Q1 2019 | $38,606,000 | +14.2% | 1,162,812 | 0.0% | 0.01% | -7.7% |
Q4 2018 | $33,803,000 | -36.8% | 1,162,812 | 0.0% | 0.01% | -23.5% |
Q3 2018 | $53,490,000 | +20.7% | 1,162,812 | -1.9% | 0.02% | +13.3% |
Q2 2018 | $44,309,000 | +21.7% | 1,185,690 | -3.8% | 0.02% | +15.4% |
Q1 2018 | $36,416,000 | -19.1% | 1,232,329 | -6.0% | 0.01% | -18.8% |
Q4 2017 | $45,007,000 | -11.6% | 1,310,443 | -6.9% | 0.02% | -15.8% |
Q3 2017 | $50,932,000 | +49.7% | 1,407,732 | +6.9% | 0.02% | +35.7% |
Q2 2017 | $34,018,000 | +40.2% | 1,316,479 | +4.2% | 0.01% | +40.0% |
Q1 2017 | $24,256,000 | +69.4% | 1,263,347 | +47.1% | 0.01% | +66.7% |
Q4 2016 | $14,319,000 | -3.5% | 858,972 | +13.8% | 0.01% | -14.3% |
Q3 2016 | $14,841,000 | -27.4% | 755,045 | +13.0% | 0.01% | -30.0% |
Q2 2016 | $20,443,000 | -1.4% | 668,070 | +20.6% | 0.01% | 0.0% |
Q1 2016 | $20,729,000 | -21.0% | 553,804 | -8.9% | 0.01% | -23.1% |
Q4 2015 | $26,236,000 | +15.2% | 607,872 | 0.0% | 0.01% | +8.3% |
Q3 2015 | $22,783,000 | +35.9% | 607,872 | +23.2% | 0.01% | +50.0% |
Q2 2015 | $16,768,000 | -30.6% | 493,323 | -27.8% | 0.01% | -33.3% |
Q1 2015 | $24,177,000 | -11.6% | 682,953 | -14.9% | 0.01% | -14.3% |
Q4 2014 | $27,335,000 | -8.1% | 802,565 | +4.0% | 0.01% | -12.5% |
Q3 2014 | $29,758,000 | -41.5% | 771,536 | -41.0% | 0.02% | +14.3% |
Q2 2014 | $50,854,000 | +127.7% | 1,306,632 | +100.0% | 0.01% | +7.7% |
Q1 2014 | $22,337,000 | +63.0% | 653,316 | 0.0% | 0.01% | +62.5% |
Q4 2013 | $13,706,000 | -1.8% | 653,316 | +10.0% | 0.01% | 0.0% |
Q3 2013 | $13,953,000 | +26.3% | 593,767 | +44.4% | 0.01% | +14.3% |
Q2 2013 | $11,048,000 | +61.3% | 411,179 | +52.4% | 0.01% | +75.0% |
Q1 2013 | $6,851,000 | -16.3% | 269,752 | -11.1% | 0.00% | -33.3% |
Q3 2012 | $8,189,000 | -3.2% | 303,422 | -10.9% | 0.01% | -14.3% |
Q2 2012 | $8,460,000 | – | 340,459 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |